A multicenter, phase IV observational safety study of ofatumumab in chronic lymphocytic leukemia (CLL): a european research initiative on CLL (EIRC) study

• Authors: MORENO C.; MONTILLO M.; PANAYIOTIDIS P.; BLOOR A.; DUPUIS J.; SCHUH A.; NORIN S.; GEISLER C.; HILLMEN P.; DOUBEK Michael; TRNĚNÝ Marek; OBRTLÍKOVÁ P.; LAURENTI L.; STILGENBAUER S.; SMOLEJ L.; GHIA P.; CYMBALISTA F.; JAEGER U.; STAMATOPOULOS K.; STAVROYIANNI N.; CARRINGTON P.; ZOUABI H.; LEBLOND V.; GOMEZ J.; MARASCA R.; MUSURACA G.; RIGACCI L; FARINA L.; PAOLINI R.; POSPÍŠILOVÁ Šárka; KIMBY E.; BRADLEY C.; MONTSERRAT E.
• Year of publication: 2013
• Type: Conference abstract
• MU Faculty or unit: Central European Institute of Technology